Shanghai Universal Biotech Co.,Ltd. (SHE:301166)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Wholesale Trade	1.12B	1.23B	1.20B	1.11B	849.08M
Wholesale Trade Growth	-8.82%	2.57%	7.70%	30.69%	7.90%
Total	1.12B	1.23B	1.20B	1.11B	849.08M
Total Growth	-8.82%	2.57%	7.70%	30.69%	7.90%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
China	1.11B	1.22B	1.19B	-	-
China Growth	-8.79%	2.29%	-	-	-
Overseas	6.16M	7.04M	3.68M	-	43.95K
Overseas Growth	-12.60%	91.43%	-	-	-99.29%
Eastern China	-	-	-	700.17M	524.18M
Eastern China Growth	-	-	-	33.57%	7.16%
North China	-	-	-	100.16M	90.47M
North China Growth	-	-	-	10.71%	2.56%
South China	-	-	-	124.30M	91.73M
South China Growth	-	-	-	35.50%	35.26%
Central China	-	-	-	-	61.36M
Central China Growth	-	-	-	-	0.29%
Southwest China	-	-	-	-	48.82M
Southwest China Growth	-	-	-	-	22.87%
Northeast China	-	-	-	-	26.91M
Northeast China Growth	-	-	-	-	-2.42%
Northwest China	-	-	-	-	5.57M
Northwest China Growth	-	-	-	-	-17.88%
Others	-	-	-	185.05M	-
Total	1.12B	1.23B	1.20B	1.11B	849.08M
Total Growth	-8.82%	2.57%	7.70%	30.69%	7.94%

Source: S&P Global Market Intelligence.